J Pediatr 121:641646 Walker JL, Crock PA, Behncken SN, Rowlinson SW, Nicholson LM, Boulton TJC, Waters MJ (1998) A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-term treatment with recombinant human insulin-like growth factor-1 and luteinizing hormone-releasing hormone analogue
Effects of pyrroloquinoline quinone supplementation on growth performance and small intestine characteristics in weaned pigs
Youve probably heard of antioxidants - but few realise that one molecule quietly outperforms them all
The estimated average weight change from baseline to the end of treatment was: 15.6% in the cagrilintide 1.2 mg group, 17.0% in the cagrilintide 2.4 mg group, and 17.0% in the cagrilintide 4.5 mg group 15.6%
International Psycogeriatrics, 2012
GLP-1 Medications and Your Vision: Balancing the Headlines with Clinical Facts Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Mr Mfazo Hove Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, was invited by Newsweek to comment on new research linking GLP-1 medications to a rare optic nerve condition
)
